TMCnet News

Research and Markets: Nocturia Forecast in 8 Major Markets 2015-2025 - Gain Further Insight into the Prevalence of the Subdivided Types of Nocturia

[August 14, 2015]

Research and Markets: Nocturia Forecast in 8 Major Markets 2015-2025 - Gain Further Insight into the Prevalence of the Subdivided Types of Nocturia

Research and Markets (http://www.researchandmarkets.com/research/vbcjhj/epiomic) has announced the addition of the "Epiomic Epidemiology Series: Nocturia Forecast in 8 Major Markets 2015-2025" report to their offering.

Nocturia is a relatively common urological problem and involves waking up more than twice during the night to void the bladder. Nocturia tends to be caused by other underlying diseases and processes, such as polyuria, Benign Prostatic Hyperplasia (BPH) or bladder storage disorders. This report provides the current prevalent population for Nocturia across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the types, occlusion locations and the prevalence of associated disorders of Nocturia.

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies.

Reason to Purchase:

Able to quantify patient populations in global Nocturia's market to target the development of future products, pricing strategies and launch plans
Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors and Prevention

4. Diagnosis of the Disease

5. Variation by Geography/ Ethnicity

6. Disease Prognosis (News - Alert) and Clinical Course

7. Key Co-Morbid Conditions / Features associated with the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-Line Prevalence for Nocturia

10. Main Features of Nocturia Patients

11. Abbreviations used in the Report